Pfizer Recalls Bubble Gum-Flavored Children’s Advil

Mismatched dosage cups and overdose concerns have prompted a voluntary recall of Children’s Advil Suspension.

Recalled Children's Advil / Image: Arizona's Family
Recalled Children's Advil / Image: Arizona's Family

A recent Today article noted the recall of a lot of bubble gum-flavored Children’s Advil suspension medicine. Action was taken after Pfizer, maker of the medicine, received complaints from consumers who noticed a discrepancy between the instructions and the packaging. Apparently the 4-ounce bottles were packaged with cups marked in teaspoons, while the instructions contained measurements in millimeters.

Pfizer hasn’t mentioned whether or not there have been any reports of injury, but they did release a statement noting the most common symptoms associated with ibuprofen overdose, which include nausea, vomiting, headache, drowsiness, blurred vision, and dizziness.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report